The shortage of physicians qualified to conduct clinical research in addiction and of physicians who are sufficiently trained in substance abuse to translate research to practice is a problem. The former limits scientific advancement and the latter misses opportunities to provide optimal care for patients with substance abuse. This competing continuation grant - led by established physician-researchers at Boston Medical Center and the Boston University School of Medicine - will advance the Clinical Addiction Research and Education (CARE) Program, which has successfully fostered physician development in addiction research and education over the past 5 years. The program will pursue 4 goals: 1. Develop generalist physicians to become capable researchers in drug abuse by supporting a fellowship in drug abuse research, which will be part of an existing General Internal Medicine/Family Medicine program. 2. Train Chief Resident (CR) educators to teach state-of-the-art methods in clinical addiction practice by hosting a conference that will build skills in screening, assessing, and treating substance abuse;the conference will also highlight opportunities for physicians in clinical research careers focused on drug abuse. 3. Introduce medical students to clinical research careers in drug abuse by providing them opportunities to work with faculty on drug abuse research projects during a summer research program. 4. Ensure that physicians-in-training and physician-researchers in drug abuse are aware of the clinically relevant drug abuse research by producing and disseminating a high-quality newsletter that summarizes timely research findings. It is expected that the CARE program will continue to engage junior investigators to pursue career opportunities in addictions research and that chief residents will implement curriculum changes in their residency programs that incorporate research-based methods in drug abuse treatment. The program is significant, because it will help bridge the gap between research and clinical practice in drug abuse. Relevance to Public Health: This comprehensive effort will help the spectrum of young physicians (i.e., from medical students to fellows) apply advances in drug abuse care and research to """"""""real-world"""""""" practice. It will also inspire some of these physicians to make important contributions to research. Both will ultimately improve patient care and reduce the medical, social, and financial burden of drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Education Projects (R25)
Project #
5R25DA013582-10
Application #
7808075
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Denisco, Richard A
Project Start
2001-05-01
Project End
2011-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
10
Fiscal Year
2010
Total Cost
$318,626
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Weinstein, Zoe M; Gryczynski, Gabriela; Cheng, Debbie M et al. (2018) Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend 189:166-171
Alford, Daniel P; Carney, Brittany L; Jackson, Angela H et al. (2018) Promoting addiction medicine teaching through functional mentoring by co-training generalist chief residents with faculty mentors. Subst Abus :1-7
Barocas, Joshua A; White, Laura F; Wang, Jianing et al. (2018) Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health 108:1675-1681
Hadland, Scott E; Bagley, Sarah M; Rodean, Jonathan et al. (2018) Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. JAMA Pediatr 172:1029-1037
Morgan, Jake R; Schackman, Bruce R; Leff, Jared A et al. (2018) Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat 85:90-96
Bagley, Sarah M; Cheng, Debbie M; Winter, Michael et al. (2018) Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Drug Alcohol Depend 192:245-249
Idrisov, Bulat; Lunze, Karsten; Cheng, Debbie M et al. (2017) Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia. Addict Sci Clin Pract 12:30
Weinstein, Zoe M; Cheng, Debbie M; Quinn, Emily et al. (2017) Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. Drug Alcohol Depend 170:9-16
Hui, David; Weinstein, Zoe M; Cheng, Debbie M et al. (2017) Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat 79:12-19
Trowbridge, Paul; Weinstein, Zoe M; Kerensky, Todd et al. (2017) Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat 79:1-5

Showing the most recent 10 out of 57 publications